Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Shandong Loncom Pharmaceutical

02 3APGDI

03 1Adalvo

04 3Alkem Laboratories

05 2Alter Laboratories Sa

06 4Apotex Inc

07 20Astellas Pharma

08 1Aurobindo Pharma Limited

09 1Avansor Pharma Oy

10 1CLONMEL HLTHCARE

11 1Cinfa

12 2Cipla Medpro South Africa

13 2Deva Holding AS

14 1GSK

15 1Glenmark Pharmaceuticals

16 2KMS Health Center

17 1LABORATORIOS NORMON SA

18 2Lupin Ltd

19 2MSN Laboratories

20 2Pharmathen SA

21 1Q Pharma Laboratories Sl

22 2Qilu Pharmaceutical

23 3STADA Arzneimittel

24 2Sawai Pharmaceutical Co

25 1Sunshine Lake Pharma

26 2Tecnimede

27 3Teva Pharmaceutical Industries

28 2Unichem Laboratories Limited

29 1Whanin Pharmaceutical

30 4Zentiva

31 2Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.

Regulatory Info :

Registration Country : China

Mirabegron

Brand Name : Mirabegron

Dosage Form : Tablet

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : China

Shandong Loncom Pharmaceutical company banner

02

Alkem Laboratories

PEGS Boston Summit
Not Confirmed
arrow

Alkem Laboratories

arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2024-02-12

Application Number : 215948

Regulatory Info : RX

Registration Country : USA

blank

03

Alkem Laboratories

PEGS Boston Summit
Not Confirmed
arrow

Alkem Laboratories

arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2024-02-12

Application Number : 215948

Regulatory Info : RX

Registration Country : USA

blank

04

APGDI

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

APGDI

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2012-06-28

Application Number : 202611

Regulatory Info : RX

Registration Country : USA

blank

05

APGDI

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

APGDI

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2012-06-28

Application Number : 202611

Regulatory Info : RX

Registration Country : USA

blank

06

APGDI

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

APGDI

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MYRBETRIQ GRANULES

Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG/ML

Packaging :

Approval Date : 2021-03-25

Application Number : 213801

Regulatory Info : RX

Registration Country : USA

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2025-01-02

Application Number : 209434

Regulatory Info : DISCN

Registration Country : USA

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-01-02

Application Number : 209434

Regulatory Info : DISCN

Registration Country : USA

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 209413

Regulatory Info :

Registration Country : USA

blank

10

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2022-09-28

Application Number : 209485

Regulatory Info : RX

Registration Country : USA

blank

11

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2022-09-28

Application Number : 209485

Regulatory Info : RX

Registration Country : USA

blank

12

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2025-11-04

Application Number : 218543

Regulatory Info : RX

Registration Country : USA

blank

13

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-11-04

Application Number : 218543

Regulatory Info : RX

Registration Country : USA

blank

14

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2025-06-30

Application Number : 217989

Regulatory Info : RX

Registration Country : USA

blank

15

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-06-30

Application Number : 217989

Regulatory Info : RX

Registration Country : USA

blank

16

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2019-12-27

Application Number : 209446

Regulatory Info : DISCN

Registration Country : USA

blank

17

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2025-05-06

Application Number : 217061

Regulatory Info : DISCN

Registration Country : USA

blank

18

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 216757

Regulatory Info :

Registration Country : USA

blank

19

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2022-09-29

Application Number : 209488

Regulatory Info : RX

Registration Country : USA

blank

20

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

MIRABEGRON

Brand Name : MIRABEGRON

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2022-09-29

Application Number : 209488

Regulatory Info : RX

Registration Country : USA

blank